SCHEMBL8144342

SCHEMBL8144342

COC(=O)Cc1ccc(CCC(CCc2ccc(CC(=O)OC)cc2)C(=O)O)cc1

nearest known ligand 0.62

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CYP4F2 P78329 1/20 0.62
CYP4A11 Q02928 1/20 0.62
ALDH1A1 P00352 4/20 0.46
SLC7A5 Q01650 1/20 0.46
LMNA P02545 2/20 0.45
GAA P10253 1/20 0.44
GFER P55789 1/20 0.44
HSP90AB1 P08238 1/20 0.43
HPGD P15428 1/20 0.43
CNR2 P34972 1/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
MAPT P10636 1/20 0.41
NPC1 O15118 1/20 0.41
TP53 P04637 1/20 0.41
RAB9A P51151 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
TSHR P16473 1/20 0.41
EPHX2 P34913 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8158263 0.92 CYP4F2 (0.57) CYP4F2CYP4A11ALDH1A1SLC7A5LMNA
SCHEMBL8700502 0.81 CA12 (0.51) ALDH1A1LMNATSHR
SCHEMBL8135908 0.80 CYP4F2 (0.67) CYP4F2CYP4A11ALDH1A1LMNAGAA
SCHEMBL2160659 0.80 CYP4A11 (0.58) CYP4F2CYP4A11ALDH1A1HPGDMAPT
SCHEMBL4113212 0.80 CYP4F2 (0.76) CYP4F2CYP4A11ALDH1A1LMNAGAA
SCHEMBL8427671 0.79 CYP4F2 (0.70) CYP4F2CYP4A11ALDH1A1SLC7A5LMNA
SCHEMBL8141547 0.79 CYP4F2 (0.60) CYP4F2CYP4A11ALDH1A1LMNAGAA
SCHEMBL11576249 0.79 CYP4F2 (0.60) CYP4F2CYP4A11ALDH1A1LMNAGAA
SCHEMBL15586041 0.78 CYP4A11 (0.75) CYP4F2CYP4A11ALDH1A1LMNAGAA
SCHEMBL11493064 0.78 CYP4A11 (0.75) CYP4F2CYP4A11ALDH1A1LMNAGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8217063-B2 Lactam-substituted dicarboxylic acids and use thereof BAYER INTELLECTUAL PROPERTY GMBH (DE) 2012-07-10 US disclosed
EP-2142504-B1 LACTAM-SUBSTITUTED DICARBOXYLIC ACIDS AND USE THEREOF Bayer Pharma AG (DE) 2011-10-26 EP disclosed
US-7985876-B2 Substituted dibenzoic acid derivatives and use thereof BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2011-07-26 US disclosed
US-20100197680-A1 LACTAM-SUBSTITUTED DICARBOXYLIC ACIDS AND USE THEREOF BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2010-08-05 US disclosed
US-20100168240-A1 SUBSTITUTED DIBENZOIC ACID DERIVATIVES AND USE THEREOF BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2010-07-01 US disclosed
WO-2008119457-A2 LACTAM-SUBSTITUTED DICARBOXYLIC ACIDS AND USE THEREOF BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2008-10-09 WO disclosed
WO-2008119458-A1 SUBSTITUTED DIBENZOIC ACID DERIVATIVES AND USE THEREOF BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2008-10-09 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100168240-A1 SUBSTITUTED DIBENZOIC ACID DERIVATIVES AND USE THEREOF BBOX1, DDC, DDT CYP4F2 76/4885CYP4A11 158/4885ALDH1A1 27/4885
US-20100197680-A1 LACTAM-SUBSTITUTED DICARBOXYLIC ACIDS AND USE THEREOF DDO, DDC, BCAT2 CYP4F2 672/4885CYP4A11 2160/4885ALDH1A1 1142/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.